Barclays »

Immunovant shares owned by Barclays

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Barclays

Quarter filed Position value Share count Share price at filing
2024-12-31 $13M 510k 24.77
2024-09-30 $12M 418k 28.51
2024-06-30 $4.8M 183k 26.41
2024-03-31 $6.8M 209k 32.31
2023-12-31 $8.3M 198k 42.13
2023-09-30 $552k 14k 38.33
2023-06-30 $43k 2.3k 18.81
2023-03-31 $999 86 11.63
2022-09-30 $33k 6.0k 5.50